Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.110
+0.070 (1.73%)
Sep 11, 2026, 2:56 PM EDT - Market open
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.42 million as of September 11, 2026. Its market cap has increased by 6.81% in one year.
Market Cap
13.42M
Enterprise Value
3.98M
1-Year Change
6.81%
Ranking
Category
Stock Price
$4.11
ChartMarket Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.42M, a decrease of -79.67%. That is a compound annual growth rate of -39.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 13.42M | -45.54% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 14.67M |
| Moleculin Biotech | 14.61M |
| Moolec Science | 14.42M |
| Quoin Pharmaceuticals | 14.36M |
| CalciMedica | 13.79M |
| Pluri | 13.70M |
| Immuron | 13.52M |
| SeaStar Medical Holding | 13.00M |